vs

Side-by-side financial comparison of BK Technologies Corp (BKTI) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

BK Technologies Corp is the larger business by last-quarter revenue ($21.5M vs $13.2M, roughly 1.6× TriSalus Life Sciences, Inc.). BK Technologies Corp runs the higher net margin — 19.7% vs -73.9%, a 93.5% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 20.0%). BK Technologies Corp produced more free cash flow last quarter ($2.8M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -21.6%).

BK Technologies Corp designs, manufactures and sells analog and digital two-way radio communications equipment and related accessories. It serves public safety departments, first responders, government agencies and commercial clients primarily across North America, focusing on reliable, mission-critical communication solutions.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

BKTI vs TLSI — Head-to-Head

Bigger by revenue
BKTI
BKTI
1.6× larger
BKTI
$21.5M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+39.9% gap
TLSI
59.8%
20.0%
BKTI
Higher net margin
BKTI
BKTI
93.5% more per $
BKTI
19.7%
-73.9%
TLSI
More free cash flow
BKTI
BKTI
$5.4M more FCF
BKTI
$2.8M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-21.6%
BKTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKTI
BKTI
TLSI
TLSI
Revenue
$21.5M
$13.2M
Net Profit
$4.2M
$-9.8M
Gross Margin
50.5%
86.7%
Operating Margin
19.7%
-24.8%
Net Margin
19.7%
-73.9%
Revenue YoY
20.0%
59.8%
Net Profit YoY
15.6%
3.5%
EPS (diluted)
$1.06
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKTI
BKTI
TLSI
TLSI
Q4 25
$21.5M
$13.2M
Q3 25
$24.4M
$11.6M
Q2 25
$21.2M
$11.2M
Q1 25
$19.1M
$9.2M
Q4 24
$17.9M
$8.3M
Q3 24
$20.2M
$7.3M
Q2 24
$20.3M
$7.4M
Q1 24
$6.5M
Net Profit
BKTI
BKTI
TLSI
TLSI
Q4 25
$4.2M
$-9.8M
Q3 25
$3.4M
$-10.8M
Q2 25
$3.7M
$-8.3M
Q1 25
$2.1M
$-10.4M
Q4 24
$3.7M
$-10.1M
Q3 24
$2.4M
$-2.4M
Q2 24
$1.7M
$-4.3M
Q1 24
$-13.2M
Gross Margin
BKTI
BKTI
TLSI
TLSI
Q4 25
50.5%
86.7%
Q3 25
49.9%
83.5%
Q2 25
47.4%
83.9%
Q1 25
47.0%
83.7%
Q4 24
41.2%
85.3%
Q3 24
38.8%
86.3%
Q2 24
37.3%
87.6%
Q1 24
85.0%
Operating Margin
BKTI
BKTI
TLSI
TLSI
Q4 25
19.7%
-24.8%
Q3 25
19.8%
-77.9%
Q2 25
18.9%
-65.4%
Q1 25
15.3%
-79.9%
Q4 24
12.3%
-91.8%
Q3 24
12.9%
-118.9%
Q2 24
10.0%
-111.0%
Q1 24
-180.8%
Net Margin
BKTI
BKTI
TLSI
TLSI
Q4 25
19.7%
-73.9%
Q3 25
14.1%
-93.5%
Q2 25
17.7%
-73.9%
Q1 25
11.2%
-113.2%
Q4 24
20.4%
-122.4%
Q3 24
11.7%
-32.6%
Q2 24
8.2%
-58.8%
Q1 24
-204.5%
EPS (diluted)
BKTI
BKTI
TLSI
TLSI
Q4 25
$1.06
$-0.22
Q3 25
$0.87
$-0.96
Q2 25
$0.96
$-0.27
Q1 25
$0.55
$-0.39
Q4 24
$0.96
$-0.38
Q3 24
$0.63
$-0.12
Q2 24
$0.47
$-0.21
Q1 24
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKTI
BKTI
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$22.8M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$44.7M
$-33.9M
Total Assets
$63.8M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKTI
BKTI
TLSI
TLSI
Q4 25
$22.8M
$20.4M
Q3 25
$21.5M
$22.7M
Q2 25
$11.9M
$26.5M
Q1 25
$8.9M
$13.0M
Q4 24
$7.1M
$8.5M
Q3 24
$4.2M
$11.3M
Q2 24
$3.0M
$16.5M
Q1 24
$4.0M
Stockholders' Equity
BKTI
BKTI
TLSI
TLSI
Q4 25
$44.7M
$-33.9M
Q3 25
$41.0M
$-26.7M
Q2 25
$36.8M
$-19.4M
Q1 25
$32.4M
$-34.4M
Q4 24
$29.8M
$-25.9M
Q3 24
$26.0M
$-20.4M
Q2 24
$23.4M
$-25.3M
Q1 24
$-36.0M
Total Assets
BKTI
BKTI
TLSI
TLSI
Q4 25
$63.8M
$35.3M
Q3 25
$66.9M
$36.5M
Q2 25
$60.4M
$41.3M
Q1 25
$56.1M
$28.6M
Q4 24
$51.5M
$24.0M
Q3 24
$46.4M
$27.5M
Q2 24
$48.9M
$32.4M
Q1 24
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKTI
BKTI
TLSI
TLSI
Operating Cash FlowLast quarter
$3.0M
$-2.5M
Free Cash FlowOCF − Capex
$2.8M
$-2.5M
FCF MarginFCF / Revenue
13.2%
-19.1%
Capex IntensityCapex / Revenue
0.7%
0.3%
Cash ConversionOCF / Net Profit
0.71×
TTM Free Cash FlowTrailing 4 quarters
$18.4M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKTI
BKTI
TLSI
TLSI
Q4 25
$3.0M
$-2.5M
Q3 25
$10.4M
$-3.7M
Q2 25
$3.9M
$-7.3M
Q1 25
$2.1M
$-4.5M
Q4 24
$3.8M
$-5.7M
Q3 24
$5.7M
$-10.8M
Q2 24
$4.1M
$-13.4M
Q1 24
$-10.9M
Free Cash Flow
BKTI
BKTI
TLSI
TLSI
Q4 25
$2.8M
$-2.5M
Q3 25
$10.1M
$-3.9M
Q2 25
$3.7M
$-7.4M
Q1 25
$1.8M
$-5.3M
Q4 24
$3.4M
$-5.8M
Q3 24
$5.2M
$-11.0M
Q2 24
$3.9M
$-13.5M
Q1 24
$-10.9M
FCF Margin
BKTI
BKTI
TLSI
TLSI
Q4 25
13.2%
-19.1%
Q3 25
41.3%
-33.9%
Q2 25
17.3%
-66.1%
Q1 25
9.6%
-57.3%
Q4 24
19.2%
-69.7%
Q3 24
25.8%
-149.9%
Q2 24
19.2%
-183.1%
Q1 24
-169.3%
Capex Intensity
BKTI
BKTI
TLSI
TLSI
Q4 25
0.7%
0.3%
Q3 25
1.5%
1.9%
Q2 25
1.2%
0.8%
Q1 25
1.4%
8.2%
Q4 24
2.0%
0.6%
Q3 24
2.2%
2.3%
Q2 24
1.0%
0.8%
Q1 24
1.0%
Cash Conversion
BKTI
BKTI
TLSI
TLSI
Q4 25
0.71×
Q3 25
3.04×
Q2 25
1.04×
Q1 25
0.98×
Q4 24
1.04×
Q3 24
2.40×
Q2 24
2.46×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons